
Govt initiates raft of measures to shore up medical infrastructure
Hyderabad: In an effort to tackle the shortage of teaching faculty in government medical colleges, the government has initiated several measures, including taking up recruitments and also improving infrastructure.
According to the officials, just two days ago, the Medical and Health Services Recruitment Board issued a notification to fill 607 assistant professor posts. The Finance Department approved the recruitment of an additional 714 posts, which will be filled shortly. Since direct recruitment for Associate Professor, Professor, and Additional DME posts was not permissible, these positions are being filled through promotions. To enable this, the government has granted panel year relaxation, according to Medical Education officials.
The government has begun promoting around 231 Assistant Professors as Associate Professors. Promotions have been granted to 308 Associate Professors, elevating them to Professor positions. This move will address shortages of Professors and Heads of Departments across colleges.
Additionally, 44 eligible senior professors have been promoted as Additional Directors of Medical Education. These promotions will result in the appointment of regular Principals in all 34 government medical colleges and regular Superintendents in teaching hospitals.
Regarding the Infrastructure, by 2021, Telangana had only nine medical colleges. The then government established eight colleges in 2022 and another nine in 2023. In 2024, GOs were issued for setting up 8 more colleges. However, in 2022 and 2023, 17 colleges were started without dedicated college buildings, hostel buildings, or affiliated hospitals. The previous government obtained approvals from the NMC by showcasing rented buildings and warehouses as colleges, despite lacking even basic facilities. As a result, the sudden increase in colleges from nine to 34 led to severe shortages of faculty and essential infrastructure.
To overcome these challenges and systematically develop the colleges and teaching hospitals, the present government laid out a clear roadmap. Through GO 276, Medical College Monitoring Committees (MCMCs) were constituted.
These committees are visiting all colleges to assess and report on multiple aspects to the government, including infrastructure, human resources, academic and curriculum readiness, student welfare and amenities, operational and financial aspects, digital systems and IT Infrastructure. Based on their reports, the government is taking steps to develop each college and hospital.
On the new hostels and reconstruction of Osmania, Raja Narsimha said that for a decade, junior doctors and faculty fought for the construction of a new Osmania Hospital. Fulfilling this long-standing aspiration, the government initiated the construction of the new Osmania Hospital at Goshamahal. In addition, modern hostel buildings worth approximately Rs 127 crore were being built with state-of-the-art facilities for Osmania and Gandhi Medical College students. In all these ways, the government under Chief Minister A Revanth Reddy and Minister Damodar Raja Narsimha is working to honour the aspirations of doctors and fulfill their goals, said a press release issued here on Sunday.
Earlier, the Government has decided to continue the services of 16,448 posts under the DME for another one year, which avoids staffing gaps until regular recruitment happens. As per this GO the government has given approval for the continuation of 16,448 posts under the Director of Medical Education (DME) for one more year from April 1, 2025 to March 31, 2026.
The posts include 4,772 Contract posts, 8,615 Outsourcing posts, 3,056 Honorarium posts, 5 MTS (Multi-tasking staff). These posts cover all govt medical colleges, teaching hospitals, nursing and dental colleges across Telangana. It includes faculty (Professors, SRs), doctors, nurses, paramedical staff, DEOs, Class-IV staff and many support roles. All existing contracts will be renewed and new agreements signed as per norms.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
an hour ago
- Economic Times
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Fortis Healthcare is poised for robust growth, driven by hospital expansion and a turnaround in its diagnostics business. With plans to add 900+ beds and expectations of 14–15% revenue growth in FY26, analysts remain bullish. Brownfield expansions and improving ARPOB are likely to support margin improvement and top-line growth. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.


Time of India
an hour ago
- Time of India
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the stock. The company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by FY27. In February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is expected. In the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding exercise. Consolidated EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 crore. Live Events The diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.


Time of India
3 hours ago
- Time of India
Chhattisgarh set to become national, international centre for Ayurveda: CM Sai
Durg: Chhattisgarh, which has a rich forest cover, is poised to become a national and international centre for Ayurveda, Chief Minister Vishnu Deo Sai said on Sunday. He was speaking after inaugurating an advanced Ayurvedic medicine processing facility and central warehouse complex at Jamgaon in Durg district. The unit, developed by the Chhattisgarh State Minor Forest Produce Cooperative Federation, will also have a herbal extraction set-up established through a public-private partnership with Sprayer Biotech Private Limited, he said. The CM said the unit is expected to generate 2,000 direct and indirect jobs. "With nearly 44 per cent of Chhattisgarh's landmass under forest cover, this initiative is both a privilege and a responsibility. The raw materials for Ayurvedic formulations will be sustainably sourced from our forests, ensuring tangible economic benefits for tribal communities," he said. He described the processing unit as the largest of its kind in Central India and a milestone that will enhance healthcare delivery while positioning Chhattisgarh as a recognised national and international centre of Ayurveda. The CM said that the state government is steadfastly fulfilling the guarantees made by Prime Minister Narendra Modi. "Over the past 18 months, we have been resolutely advancing the state's development agenda. Every promise made to the 3 crore citizens of Chhattisgarh is being honoured with utmost priority," Sai said. He said the government's decision to hike the procurement rate for tendu leaves from Rs 4,500 to Rs 5,500 per standard sack is benefiting nearly 1.3 million tendu leaf collector families. He also highlighted the revival of the 'Charan Paduka Yojana', under which protective footwear is distributed to forest workers. Five women beneficiaries received footwear during the event. Appealing to citizens to participate in the 'Ek Ped Maa Ke Naam' (One Tree in Mother's Name) campaign, the CM urged every individual to plant at least one sapling as a tribute to their mother and nature. Forest Minister Kedar Kashyap, who also attended the event, called the facility a vital step towards streamlining the collection, processing, and marketing of forest resources. He said that the state collects 67 varieties of minor forest produce, benefitting over 1.34 million forest-dependent families. The Ayurvedic processing unit reflects the efforts to integrate Chhattisgarh's abundant forest resources with modern scientific techniques, realising the 'Forest to Pharmacy' model, he said. Built over 27.87 acres at Rs 36.47 crore, the facility is projected to produce Rs 50 crore Ayurvedic products annually, said officials. Medicinal and minor forest produce like mahua, sal seeds, kalmegh, giloy, and ashwagandha will be processed into powders, syrups, oils, tablets, and avaleha under stringent quality standards, they said. The unit will also serve as a key hub for promoting the 'Chhattisgarh Herbals' brand across national and international markets. Technical training programmes will enable local youth to acquire skills and access new avenues of employment, they said. A modern warehouse with a capacity of 20,000 metric tonnes has also been constructed to facilitate long-term storage and quality control of seasonal produce. The initiative embodies PM Modi's vision of 'Vocal for Local' and 'Atmanirbhar Bharat', they added. PTI